A primer on continuous renal replacement therapy for critically ill patients

被引:64
作者
Joy, MS
Matzke, GR
Armstrong, DK
Marx, MA
Zarowitz, BJ
机构
[1] Univ Pittsburgh, Sch Pharm, Ctr Clin Pharmacol, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Ctr Clin Pharmacol, Pittsburgh, PA 15261 USA
[3] Univ N Carolina, Sch Med, Div Nephrol & Hypertens, Chapel Hill, NC USA
[4] Quorum HealthGrp Inc, Clin Pharm Serv, Brentwood, TN USA
[5] Owen Healthcare Inc, Houston, TX USA
[6] Univ Arkansas Med Sci, Dept Med, Div Nephrol, Little Rock, AR 72205 USA
[7] Univ Arkansas Med Sci, Coll Pharm, Little Rock, AR 72205 USA
[8] Henry Ford Hlth Syst, Diversified Serv Grp, Ambulatory Clin Pharm Serv, Bingham Farms, MI USA
关键词
acute renal failure; critical care;
D O I
10.1345/aph.17105
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: TO characterize the multiple continuous renal replacement therapy (CRRT) techniques available for the management of critically ill adults, and to review the indications for and complications of use, principles of drug removal during CRRT, drug dosage individualization guidelines, and the influence of CRRT on patient outcomes. DATA SOURCES: MEDLINE (January 1981-December 1996) was searched for appropriate publications by using terms such as hemofiltration, ultrafiltration, hemodialysis, hemodiafiltration, medications, and pharmacokinetics; selected articles were cross-referenced, STUDY SELECTION: References selected were those considered to enhance the reader's knowledge of the principles of CRRT, and to provide adequate therapies on drug disposition. DATA SYNTHESIS: CRRTs use filtration/convection and in some cases diffusion to treat hemodynamically unstable patients with fluid overload and/or acute renal failure. Recent data suggest that positive outcomes may also be attained in patients with other medical conditions such as septic shock, multiple organ dysfunction syndrome, and hepatic failure. Age, ventilator support, inotropic support, reduced urine volume, and elevated serum bilirubin concentrations have been associated with poor outcomes. Complications associated with CRRT include bleeding due to excessive anticoagulation and Line disconnections, fluid and electrolyte imbalance, and filter and venous clotting, CRRT can complicate the medication regimens of patients for whom it is important to maintain drug plasma concentrations within a narrow therapeutic range, Since the physicochemical characteristics of a drug and procedure-specific factors can alter drug removal, a thorough assessment of all factors needs to be considered before dosage regimens are revised. In addition, an algorithm for drug dosing considerations based on drug and CRRT characteristics, as well as standard pharmacokinetic equations, is proposed. CONCLUSIONS: The use of CRRT has expanded to encompass the treatment of disease states other than just acute renal failure, Since there is great variability among treatment centers, it is premature to conclude that there is enhanced survival in CRRT-treated patients compared with those who received conventional hemodialysis, This primer may help clinicians understand the need to individualize these therapies and to prospectively optimize the pharmacotherapy of their patients receiving CRRT.
引用
收藏
页码:362 / 375
页数:14
相关论文
共 120 条
[21]  
Clark W R, 1997, Adv Ren Replace Ther, V4, P64
[22]   Solute control in acute renal failure: Prescription and delivery of adequate extracorporeal therapy [J].
Clark, WR ;
Mueller, BA ;
Kraus, MA ;
Macias, WL .
SEMINARS IN DIALYSIS, 1996, 9 (02) :133-139
[23]  
Conger J, 1997, Adv Ren Replace Ther, V4, P25
[24]   The role of continuous renal replacement therapy in the future treatment of acute renal failure [J].
Conger, JD .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (05) :S108-S113
[25]  
Coraim F I, 1995, New Horiz, V3, P725
[26]   HYPERLACTATEMIA AND METABOLIC-ACIDOSIS DURING HEMOFILTRATION USING LACTATE-BUFFERED FLUIDS [J].
DAVENPORT, A ;
WILL, EJ ;
DAVISON, AM .
NEPHRON, 1991, 59 (03) :461-465
[27]  
Davenport A, 1995, New Horiz, V3, P717
[28]   The management of established renal failure in patients with liver failure [J].
Davenport, A .
SEMINARS IN DIALYSIS, 1996, 9 (02) :166-172
[29]   COMPARISON OF THE USE OF STANDARD HEPARIN AND PROSTACYCLIN ANTICOAGULATION IN SPONTANEOUS AND PUMP-DRIVEN EXTRACORPOREAL CIRCUITS IN PATIENTS WITH COMBINED ACUTE RENAL AND HEPATIC-FAILURE [J].
DAVENPORT, A ;
WILL, EJ ;
DAVISON, AM .
NEPHRON, 1994, 66 (04) :431-437
[30]   Quinine clearance in continuous venovenous hemofiltration [J].
Davies, JG ;
Greenwood, EF ;
Kingswood, JC ;
Sharpstone, P ;
Street, MK .
ANNALS OF PHARMACOTHERAPY, 1996, 30 (05) :487-490